A prospective test of the late effects of potentially antineuroplastic drugs in a stroke rehabilitation study

International Journal of Stroke

Volumn 9, Issue 4, 2014, Pages 449-456

  Nadeau, Stephen E ^a,b   Lu, Xiaomin ^c   Dobkin, Bruce ^d   Wu, Samuel S ^c   Dai, Yunfeng E ^c   Duncan, Pamela W ^e  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

^c UNIVERSITY OF FLORIDA   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

^e WAKE FOREST SCHOOL OF MEDICINE   (United States)

Author keywords

Alpha 1 noradrenergic blockers; Alpha 2 noradrenergic agonists; Anticonvulsants; Neurorehabilitation; Voltage sensitive calcium channel blockers

Indexed keywords

ALPHA 1 ADRENERGIC RECEPTOR BLOCKING AGENT; ALPHA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; ANTICONVULSIVE AGENT; BENZATROPINE; BENZODIAZEPINE DERIVATIVE; CALCIUM CHANNEL BLOCKING AGENT; CARBAMAZEPINE; CLONIDINE; DOXAZOSIN; ETIRACETAM; GABAPENTIN; LAMOTRIGINE; NEUROLEPTIC AGENT; PHENOBARBITAL; PHENYTOIN; PRAZOSIN; PREGABALIN; SEROTONIN UPTAKE INHIBITOR; TAMSULOSIN; TERAZOSIN; TOPIRAMATE; TRICYCLIC ANTIDEPRESSANT AGENT; VALPROIC ACID; VOLTAGE GATED SODIUM CHANNEL BLOCKING AGENT; AGENTS INTERACTING WITH TRANSMITTER, HORMONE OR DRUG RECEPTORS;

ADULT; ANTICHOLINERGIC EFFECT; ARM; ARTICLE; CEREBROVASCULAR ACCIDENT; COGNITIVE DEFECT; CONTROLLED STUDY; DEPRESSION; DRUG EFFICACY; EXERCISE; FEMALE; FUNCTIONAL STATUS; HUMAN; LACUNAR STROKE; LEG; MAJOR CLINICAL STUDY; MALE; MOTOR COORDINATION; NERVE CELL PLASTICITY; PHYSIOTHERAPY; PRIORITY JOURNAL; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; RANGE OF MOTION; REHABILITATION; TREATMENT DURATION; TREATMENT OUTCOME; WALKING; WALKING SPEED; CLINICAL TRIAL; DRUG EFFECTS; LOCOMOTION; MULTICENTER STUDY; PHYSIOLOGY; REHABILITATION CENTER; SINGLE BLIND PROCEDURE; STATISTICAL MODEL; STROKE;

FEMALE; HUMANS; LOCOMOTION; LOGISTIC MODELS; MALE; NEUROTRANSMITTER AGENTS; PHYSICAL THERAPY MODALITIES; PROSPECTIVE STUDIES; REHABILITATION CENTERS; SINGLE-BLIND METHOD; STROKE; TREATMENT OUTCOME;

EID: 84899743332     PISSN: 17474930     EISSN: 17474949     Source Type: Journal    
DOI: 10.1111/j.1747-4949.2012.00920.x     Document Type: Article

References (36)

1. Iadecola C, Anrather J. Stroke research at a crossroad: asking the brain for directions. Nat Neurosci 2011; 14:1363-1368.
2. Wieloch T, Nikolich K. Mechanisms of neural plasticity following brain injury. Curr Opin Neurol 2006; 16:258-264.
3. Dancause N, Nudo RJ. Shaping plasticity to enhance recovery after injury. Prog Brain Res 2011; 192:273-295.
4. Goldstein LB. Common drugs may influence motor recovery after stroke. Sygen in Acute Stroke Study Investigators. Neurology 1995; 45:865-871.
5. Gonzalez Rothi LJ, Fuller R, Leon SA etal. Errorless practice as a possible adjuvant to donepezil in Alzheimer's disease. J Int Neuropsychol Soc 2009; 15:311-321.
6. Brailowsky S, Knight RT, Efron R. Phenytoin increases the severity of cortical hemiplegia in rats. Brain Res 1986; 376:71-77.
7. Hernandez TD, Holling LC. Disruption of behavioral recovery by the anti-convulsant phenobarbital. Brain Res 1994; 635:300-306.
8. Feeney DM, Westerberg VS. Norepinephrine and brain damage: alpha noradrenergic pharmacology alters functional recovery after cortical trauma. Can J Psychol 1990; 44:233-252.
9. Goldstein LB, Davis JN. Clonidine impairs recovery of beam-walking in rats. Brain Res 1990; 362:305-309.
10. Schallert T, Hernandez TD, Barth TM. Recovery of function after brain damage: severe and chronic disruption by diazepam. Brain Res 1986; 379:104-111.
11. Moratalla R, Barth TM, Bowery NG. Benzodiazepine receptor autoradiography in corpus striatum of rat after large frontal cortex lesions and chronic treatment with diazepam. Neuropharmacology 1989; 28:893-900.
12. Zhao CS, Puurunen K, Schallert T etal. Behavioral effects of photothrombotic ischemic cortical injury in aged rats treated with the sedative-hypnotic GABAergic drug zopliclone. Behav Brain Res 2005; 160:260-266.
13. Feeney DM, Gonzalez A, Law WA. Amphetamine, haloperidol, and experience interact to affect the rate of recovery after motor cortex injury. Science 1982; 217:855-857.
14. Goldstein LB, Bullman S. Differential effects of haloperidol and clozapine on motor recovery after sensorimotor cortex injury in rats. Neurorehabil Neural Repair 2002; 16:1-5.
15. Zhao C, Puurunen K, Schallert T etal. Behavioral and histological effects of chronic antipsychotic and antidepressant drug treatment in aged rats with focal ischemic brain injury. Behav Brain Res 2005; 158:211-220.
16. Drachman DA, Leavitt J. Human memory and the cholinergic system. Arch. Neurology 1974; 30:113-121.
17. Wezenberg E, Verkes RJ, Sabbe BGC etal. Modulation of memory and visuospatial processes by biperiden and rivastigmine in elderly healthy subjects. Psychopharmacology 2005; 181:582-594.
18. Duncan PW, Sullivan KJ, Behrman AL etal. Protocol for the Locomotor Experience Applied Post-Stroke (LEAPS) trial: a randomized controlled trial. BMC Neurol 2007; 39:1-23.
19. Duncan PW, Sullivan KJ, Behrman AL etal. Body-weight - supported treadmill rehabilitation after stroke. N Engl J Med 2011; 364:2026-2036.
20. Lamiae G-B, Michel R, Elodie A etal. Agreement between patients' self-report and physicians' prescriptions on cardiovascular drug exposure: the PGRx database experience. Pharmacoepidemiol Drug Saf 2010; 19:591-595.
21. Nielsen MW, Søndergaard B, Kjøller M etal. Agreement between self-reported data on medicine use and prescriptions records vary according to method of analysis and therapeutic groups. J Clin Epidemiol 2008; 61:919-924.
22. Solomon DH, Stedman M, Licari A etal. Agreement between patient report and medical record review for medications used for rheumatoid arthritis: the accuracy of self-reported medication information in patient registries. Arthritis Rheum 2007; 57:234-239.
23. Gladstone DJ, Danells CJ, Black SE. The Fugl-Meyer assessment of motor recovery after stroke: a critical review of its measurement properties. Neurorehabil Neural Repair 2002; 16:232-240.
24. Perry J, Garrett M, Gronley JK etal. Classification of walking handicap in the stroke population. Stroke 1995; 26:982-989.
25. Schmid A, Duncan PW, Studenski S etal. Improvements in speed-based gait classifications are meaningful. Stroke 2007; 38:2096-2100.
26. Folstein MF, Folstein SE, McHugh PR. 'Mini-mental state.' A practical method for grading the cognitive state of patients for the clinician. J Psychol Res 1975; 12:189-198.
27. The Psychological Corporation. WAIS-III and WMS-III Technical Manual. San Antonio, TX, The Psychological Corporation, 1997.
28. Corrigan JD, Hinkeldey NS. Relationships between parts A and B of the Trail Making Test. J Clin Psychol 1987; 43:402-408.
29. Wang M, Gamo N, Arnsten AF etal. Neuronal basis of age-related working memory decline. Nature 2011; 476:210-213.
30. Chollet F, Tardy J, Albucher J-F etal. Fluoxetine for motor recovery after acute ischaemic stroke (FLAME): a randomised placebo-controlled trial. Lancet Neurol 2011; 10:123-130.
31. DeMaris A. Explained variance in logistic regression: a Monte Carlo study of proposed measures. Sociol Methods Res 2002; 31:27-74.
32. Williams LS, Brizendine EJ, Plue L etal. Performance of the PHQ-9 as a screening tool for depression after stroke. Stroke 2005; 36:635-638.
33. Blaschke TF, Osterberg L, Vrijens B etal. Adherence to medications: insights arising from studies on the unrelaible link between prescribd and actual drug dosing hiistories. Annu Rev Pharmacol Toxicol 2012; 52:275-301.
34. Choudhry HK, Avorn J, Glynn RJ etal. Post-Myocardial Infarction Free Rx Event and Economic Evaluation (MI FREEE) Trial. N Engl J Med 2011; 365:2088-2097.
35. Fitz-Simon N, Bennett K, Feely J. A review of studies of adherence with antihypertensive drugs using prescription databases. Ther Clin Risk Manag 2005; 1:93-106.
36. Zeber JE, Copeland LA, Pugh MJV. Variation in antiepileptic drug adherence among older patients with new-onset epilepsy. Ann Pharmacother 2010; 44:1896-1904.